Cargando…

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester

Human leukocyte antigen-G (HLA-G) has been widely acknowledged to play critical roles in fetal-maternal maintenance. However, the significance of using maternal serum sHLA-G to detect prenatal chromosomal abnormality has not been investigated. In China, prenatal screening using maternal α-fetoprotei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Danping, Zhu, Yiyang, Li, Lanfang, Xu, Yingping, Yan, Weihua, Dai, Meizhen, Gan, Linghong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7870785/ https://www.ncbi.nlm.nih.gov/pubmed/33574829 http://dx.doi.org/10.3389/fgene.2020.497264

Ejemplares similares

Zejchho shla'-shla' : to lonhez da' chheyon chhio' toz /
por: González Dillon, Mónica
Publicado: (2013)

Fetuin A Concentration in the Second Trimester Amniotic Fluid of Fetuses with Trisomy 21 Appears to Be Lower: Phenotypic Considerations
por: Iliodromiti, S., et al.
Publicado: (2012)

Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18
por: Chen, Yiming, et al.
Publicado: (2022)

HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
por: Li, Peilong, et al.
Publicado: (2021)

Study on amniotic fluid metabolism in the second trimester of Trisomy 21
por: Liu, Xiaoting, et al.
Publicado: (2019)

The Relationship between the HLA-G Polymorphism and sHLA-G Levels in Parental Pairs with High-Risk Pregnancy
por: Sipak, Olimpia, et al.
Publicado: (2019)

Umbilical Cord Diameter at Early Second Trimester: Relation to Trisomy 21
por: Hantoushzadeh, Sedigheh, et al.
Publicado: (2019)

Increased sHLA-G Is Associated with Improved COVID-19 Outcome and Reduced Neutrophil Adhesion
por: Bortolotti, Daria, et al.
Publicado: (2021)

IONA test for first‐trimester detection of trisomies 21, 18 and 13
por: Poon, L. C., et al.
Publicado: (2015)

Non-Invasive Prenatal Testing of Trisomy 18 by an Epigenetic Marker in First Trimester Maternal Plasma
por: Lee, Da Eun, et al.
Publicado: (2013)

The association of HLA-G polymorphisms and the synergistic effect of sMICA and sHLA-G with chronic kidney disease and allograft acceptance
por: Hauer, Vanessa, et al.
Publicado: (2019)

Soluble HLA-G (sHLA-G) measurement might be useful as an early diagnostic biomarker and screening test for gastric cancer
por: Mejía-Guarnizo, Lidy Vannessa, et al.
Publicado: (2023)

Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases
por: Zhang, Yanchun, et al.
Publicado: (2022)

Comparison of Efficiencies of Non-invasive Prenatal Testing, Karyotyping, and Chromosomal Micro-Array for Diagnosing Fetal Chromosomal Anomalies in the Second and Third Trimesters
por: Zhu, Yiyang, et al.
Publicado: (2019)

Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients
por: Hoffmann, Oliver, et al.
Publicado: (2023)

External fetus in fetu presenting in the second trimester: A case report and literature review
por: Zhu, Ying, et al.
Publicado: (2023)

Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker
por: Heidari, Mohammad Hassan, et al.
Publicado: (2017)

Evaluation of the Level of Salivary sHLA-G in Children Aged 3–5 Years with or without Dental Caries
por: Bijani, Mansoureh, et al.
Publicado: (2020)

Triploidy in a fetus following amniocentesis referred for maternal serum screening test at second trimester
por: Bagherizadeh, E., et al.
Publicado: (2010)

Prediction of small-for-gestational-age neonates at 33–39 weeks’ gestation in China: logistic regression modeling of the contributions of second- and third-trimester ultrasound data and maternal factors
por: Xu, Danping, et al.
Publicado: (2022)

Outcome after Prenatal Diagnosis of Trisomy 13, 18, and 21 in Fetuses with Congenital Heart Disease
por: Springer, Stephanie, et al.
Publicado: (2022)

Performance of second-trimester maternal biochemistry screening (quadruple test vs. triple test) for trisomy 21: An Indian experience
por: Sablok, Aanchal, et al.
Publicado: (2021)

Erratum to: Evaluation of sHLA-G levels in serum of patients with prostate cancer identify as a potential of tumor marker
por: Heidari, Mohammad Hassan, et al.
Publicado: (2017)

An efficient method for noninvasive prenatal diagnosis of fetal trisomy 13, trisomy 18, and trisomy 21
por: Sun, Xiaohan, et al.
Publicado: (2019)

Clinical Implications of Second and Third Trimester Surveillance Ultrasounds of Growth-Restricted Fetuses
por: Craig, Amanda M., et al.
Publicado: (2021)

Intrauterine Growth Retardation Fetus with Trisomy 16 Mosaicism
por: Chareonsirisuthigul, Takol, et al.
Publicado: (2014)

New cut-off values for screening of trisomy 21, 18 and open neural tube defects (ONTD) during the second trimester in pregnant women with advanced maternal age
por: Chen, Yiming, et al.
Publicado: (2020)

Combined fetal fraction to analyze the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18, and 21
por: Yang, Jiexia, et al.
Publicado: (2023)

Maternal Age-Specific Rates for Trisomy 21 and Common Autosomal Trisomies in Fetuses from a Single Diagnostic Center in Thailand
por: Jaruthamsophon, Kanoot, et al.
Publicado: (2016)

Identification of trisomy 18, trisomy 13, and Down syndrome from maternal plasma
por: Gekas, Jean, et al.
Publicado: (2014)

Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma
por: Agnihotri, Vertica, et al.
Publicado: (2020)

Investigating Serum sHLA-G Cooperation With MRI Activity and Disease-Modifying Treatment Outcome in Relapsing-Remitting Multiple Sclerosis
por: Amoriello, Roberta, et al.
Publicado: (2022)

Case report: A case report and literature review of complete trisomy 9
por: Xu, Chenxia, et al.
Publicado: (2023)

Second trimester fetal MRI features in a fetus with TUBB3 gene mutation
por: Guduru, Mounika, et al.
Publicado: (2020)

Cranial findings detected by second‐trimester ultrasound in fetuses with myelomeningocele: a systematic review
por: Kunpalin, Y, et al.
Publicado: (2021)

The femur too short? 1373 fetuses with short femur during second-trimester screening
por: Friebe-Hoffmann, Ulrike, et al.
Publicado: (2022)

Outcomes of Pregnancy Termination of Dead Fetus in Utero in Second Trimester by Misoprostol with Various Regimens
por: Pongsatha, Saipin, et al.
Publicado: (2022)

Clinical Efficiency of Non-invasive Prenatal Screening for Common Trisomies in Low-Risk and Twin Pregnancies
por: Xu, Yanfei, et al.
Publicado: (2021)

MicroRNAs and Fetal Brain Development: Implications for Ethanol Teratology during the Second Trimester Period of Neurogenesis
por: Miranda, Rajesh C.
Publicado: (2012)

Noninvasive Prenatal Screening Based on Second-Trimester Ultrasonographic Soft Markers in Low-Risk Pregnant Women
por: Liu, Yunyun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v5invn518g5hfemhj3u82ha4jo